Author: Shane Solger, MD
Editor: Philippe Ayres, MD
Case:
A 5-year-old girl is brought to a Vermont Ski Clinic by her parents due to a two-week history of right knee pain with associated swelling. Despite a slight limp, the child has been able to walk and is otherwise acting like herself. The parents deny associated fevers, chills, or night sweats, and the patient denies hip or ankle pain. The child has no prior medical or surgical history, allergies, or current medication usage.
During physical examination, the child is playful and smiling with normal vital signs. Bilateral hip examination is unremarkable. Her right knee is swollen and warm when compared to the left. There is, however, no erythema, induration, or pain with passive range of motion of the right knee. There is full, active range of motion of both knees without tenderness to palpation or joint laxity.
The mother notes that both herself and the patient developed a “bulls-eye” red rash during the summer months, and blood tests confirmed they both had Lyme disease. Despite the mother having received antibiotics, the parents chose to treat their daughter with a 3-month course of a “medication” called A-L Complex. This “medication” is composed of grape alcohol, roots, flowers, and a "proprietary blend" purportedly effective against not only Lyme disease but also “....Staph, Strep, Fungal and Candida forms, Trichomonas, Chlamydia, (among others).”[1]
X-ray of the right knee shows no acute fracture or dislocation but there are degenerative changes consistent with arthritis. Given the history, physical exam findings, and findings on imaging, the team landed on the diagnosis of Lyme arthritis.
Lyme disease is transmitted via a bite from the Ixodes or black-legged tick (with an attachment period of 36 to 48 hours) and infection by the spirochete Borrelia burgdorferi or Borrelia mayonii. With only 25% of patients recognizing a tick bite, it is not surprising that many individuals go on to develop symptoms of the disease.[2] The clinical presentation is similar in adults and children, and the illness is classically divided into three stages: early localized disease, early disseminated disease, and late presentations of the disease.
Table 1: Stages of Lyme Disease Stages[12]
Within 3 to 30 days, the early manifestations begin, with the most common being the classic bull’s eye rash (erythema migrans). Among 275,589 cases (208,834 confirmed and 66,755 probable) from 2008 to 2015, the CDC reported that 70% of the cohort manifested the classic rash of Lyme disease.[3]
For those without erythema migrans (EM) or misdiagnosed EM, other common early disseminated symptoms mimic viral infections, with children reporting fatigue, headache, arthralgias/myalgias, fevers, gastrointestinal symptoms, and sore throat.[4]
Lyme arthritis refers to the symptomatic aftermath of spirochetal invasion into the joints, triggering an accumulation of neutrophils, immune complexes, complement factors, and cytokines within the synovial fluid as part of the ensuing inflammatory response.[5]
Lyme arthritis typically presents as swelling in the knees, but it might involve the shoulders, ankles, elbows, wrists, or temporomandibular joint. These patients generally have pain out of proportion to the level of swelling. The joint will appear very swollen and have large effusions, but patients will complain of only a minimal amount of pain with passive movement of the joint. The majority of patients tend to develop this late complication approximately six months after the initial disease onset, a pattern consistent with our observed patient; for some, the swelling and pain might fluctuate over the course of years.[6-8]
Lyme arthritis exhibits a higher incidence among pediatric cases, aligning its occurrence closely with that of EM and reaching its peak between the ages of 10 and 14, as displayed in the CDC table below.[3]
Notably, the historical presence of a tick bite does not consistently serve as a reliable indicator, as three of 17 patients recalled a rash, and only four remembered a tick bite.[9]
Lyme arthritis might be easy to miss if you are not given the right information. In our case, the parents were not initially forthcoming with the recent history of Lyme disease until specifically questioned. Septic arthritis of the knee is a “cannot-miss diagnosis” and should be at the top of your differential.
Other pathologies to always consider with isolated joint pain/swelling are traumatic such as dislocations, fractures, meniscus and ligament tears, tendon ruptures, and tendonitis. Also consider overuse injuries such as Osgood-Schlatter disease, patellofemoral syndrome, and pes anserine bursitis.
Infectious considerations to remember are overlying soft tissue infections, osteomyelitis, acute rheumatic fever, post-streptococcal arthritis, reactive arthritis from recent viral or bacterial illnesses, or even septic arthritis of the hip with referred pain to the knee. Lastly, always consider malignancy.
Given the overlapping clinical presentations, it becomes imperative to distinguish Lyme arthritis from septic arthritis. Septic arthritis is considered an orthopedic emergency, with the classic presentation being a febrile patient with a warm, red, painful, swollen joint with limitations in both active and passive range of movement. In Lyme arthritis, a good physical examination may reveal minimal pain with movement, as observed in our patient. Additionally, the presence of polyarthritis may provide valuable diagnostic clues favoring Lyme disease over septic arthritis.[6]
The diagnosis of Lyme arthritis is made with blood testing, and there are different combinations of serological testing - ultimately, you’ll use test for IgG and IgM for Lyme disease. You should see positive IgG-positive serologies in the setting of a late manifestation, but you may not see a positive IgM. It is also important that you get a history of prior Lyme exposure, as IgM and IgG may continue to be positive for years.[10]
The decision to perform arthrocentesis to rule out septic arthritis should be made on a case-by-case basis. If the patient has the pathognomonic EM rash followed by the development of arthritis, then it is reasonable to defer arthrocentesis and await serologies while empirically treating Lyme disease, especially in the absence of systemic signs of infection or significant pain on passive range of motion.
One decision tool has been proposed to help determine the need for arthrocentesis in Lyme-endemic regions.
Lyons et al. conducted a study at eight pediatric EDs located in Lyme endemic areas. They included patients 1 to 21 years old who presented with monoarthritis and also had blood work ordered during their ED evaluation. The primary outcome was the diagnosis of a musculoskeletal infection. The authors found that among their cohort of 735 children, none of the children with septic arthritis had both a negative procalcitonin and negative CRP. For those children with a negative procalcitonin but a positive CRP, a positive/equivocal first-tier Lyme C6 enzyme immunoassay test ruled out septic arthritis.[11] The graph below describes lab cutoffs and their ability to differentiate musculoskeletal infections caused by a bacteria defined as polymyositis, septic arthritis, or osteomyelitis (MSKI = musculoskeletal infection).
This study had a large sample size and prospective design, however, there were several limitations. It only included those who presented and had these specific biomarkers obtained, which led to the loss of ~12.5% of their initial sample size; this can introduce selection bias and impact the generalizability of their findings. Whether a patient had monoarthritis was also left up to the discretion of the treating physician, which can lead to issues with interrater reliability. Furthermore, knee monoarthritis made up the majority (68%) of the joints affected, so their rule may be less applicable to other joints. The patient selection was also specific to a lyme endemic region, so the findings are not generalizable to regions with a lower prevalence of Lyme disease. Ultimately, the serology-based algorithm is not yet ready for “prime time” to dictate management, and currently, I would not rely on it to rule out septic arthritis.
The treatment for Lyme arthritis in children is straightforward and outlined below.[5]
For patients < 8 years old, the general practice is to avoid use of doxycycline, and if the patients have persistent symptoms, either a second course of the same antibiotic or observation alone is reasonable.
While we didn’t have lab work, we were in a Lyme endemic area and had a clear history of a tick bite and erythema migrans, an X-ray that didn’t show a traumatic reason for the swelling, positive serologies for Lyme, and the development of arthritis in the most commonly Lyme-affected joint in children. The patient was treated with amoxicillin for 28 days for Lyme monoarthritis.
Take Home Points
1) Lyme arthritis, a late manifestation, typically presents with joint swelling, commonly affecting the knees, characterized by minimal pain despite significant swelling.
2) Lyme arthritis is more prevalent among pediatric patients, often occurring six months after initial infection, with peak incidence between the ages 10 to 14.
3) The classic bull’s eye rash (erythema migrans) is present in 70% of Lyme disease cases; however, the absence of this rash does not rule out Lyme disease.
4) While both Lyme arthritis from septic arthritis may present with joint inflammation, clinical clues such as minimal pain with movement and polyarthritis suggest a diagnosis of Lyme arthritis.
5) The diagnosis of Lyme arthritis requires testing for IgM and IgG antibodies to confirm exposure to Borrelia burgdorferi.
6) Arthrocentesis can be considered on a case-by-case basis; a decision aid is available, but further study is warranted to determine external validity.
7) Treatment of Lyme arthritis in children involves antibiotics such as doxycycline, amoxicillin, or cefuroxime, depending on age and severity.
1) A-L complex. Five Journeys. https://fivejourneys.com/product/a-l-complex/.
2) Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med. 1996;100(5):502-508. doi:10.1016/s0002-9343(95)99915-9
3) Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme Disease - United States, 2008-2015. MMWR Surveill Summ. 2017;66(22):1-12. Published 2017 Nov 10. doi:10.15585/mmwr.ss6622a1
4) Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med. 1996;335(17):1270-1274. doi:10.1056/NEJM199610243351703
5) Lyme arthritis. Centers for Disease Control and Prevention. October 7, 2021. https://www.cdc.gov/lyme/treatment/LymeArthritis.html.
6) Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004
7) Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987;107(5):725-731. doi:10.7326/0003-4819-107-5-725
8) Miller JB, Aucott JN. Stages of Lyme Arthritis. J Clin Rheumatol. 2021;27(8):e540-e546. doi:10.1097/RHU.0000000000001513
9) Glaude PD, Huber AM, Mailman T, Ramsey S, Lang B, Stringer E. Clinical characteristics, treatment and outcome of children with Lyme arthritis in Nova Scotia. Paediatr Child Health. 2015;20(7):377-380. doi:10.1093/pch/20.7.377
10) Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33(6):780-785. doi:10.1086/322669
11) Lyons TW, Kharbanda AB, Thompson AD, et al. A Clinical Prediction Rule for Bacterial Musculoskeletal Infections in Children with Monoarthritis in Lyme Endemic Regions. Ann Emerg Med. 2022;80(3):225-234. doi:10.1016/j.annemergmed.2022.04.009
12) Hu L. Clinical manifestations of Lyme disease in adults Topic. UpToDate. https://www.uptodate.com/contents/clinical-manifestations-of-lyme-disease-in-adults?search=lyme+disease+stages&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H10. Published February 6, 2023.
payresmatch
Latest posts by payresmatch (see all)
- “Talk Dirty to Me”: Bedside Testing for Necrotizing Fasciitis - November 5, 2024
- AV Dissociation and Complete AV Block: What’s the Difference? - July 30, 2024
- Cutting it Close: One Decision, Two Lives - May 31, 2024
0 Comments